Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Fuji
Colorcon
Deloitte
Johnson and Johnson
Citi

Generated: September 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,579,869

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,579,869 protect, and when does it expire?

Patent 8,579,869 protects NORDITROPIN FLEXPRO, LEVEMIR FLEXTOUCH, NOVOLOG FLEXPEN, NOVOLOG FLEXTOUCH, NOVOLOG MIX 70/30 FLEXPEN, NOVOLOG PENFILL, FIASP FLEXTOUCH, OZEMPIC, RYZODEG 70/30, TRESIBA, SAXENDA, VICTOZA, and XULTOPHY 100/3.6, and is included in eleven NDAs.

Protection for SAXENDA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has twenty-two patent family members in thirteen countries.

Summary for Patent: 8,579,869
Title:Needle mounting system and a method for mounting a needle assembly
Abstract: A needle mounting system and methods for mounting a needle assembly on a needle mount are disclosed. The needle mounting system includes a needle hub having protrusions extending radially inward. A needle mount has a plurality of slots to receive the protrusions. The slots have a first portion that defines a passageway substantially parallel to a longitudinal axis of the needle mount and a second portion substantially perpendicular to the axis. The needle hub and mount provide a method wherein a needle assembly may be mounted on an injection device without completely rotating the needle hub relative to the needle mount.
Inventor(s): Klint; Henrik Sonderskov (Lyngby, DK), Radmer; Jim (Fredensborg, DK), Smedegaard; Jorgen K (Frederiksberg, DK), Nielsen; Jan Frank (Lyngby, DK), Jensen; Peter Moller (Horsholm, DK), Jensen; Jens Moller (Copenhagen K, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:13/370,769
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 8,579,869

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novo Nordisk Inc NORDITROPIN FLEXPRO somatropin recombinant INJECTABLE;INJECTION 021148-008 Mar 1, 2010 BX RX No No   Try a Free Trial   Try a Free Trial Y   Try a Free Trial
Novo Nordisk Inc NORDITROPIN FLEXPRO somatropin recombinant INJECTABLE;INJECTION 021148-009 Mar 1, 2010 BX RX No No   Try a Free Trial   Try a Free Trial Y   Try a Free Trial
Novo Nordisk Inc NORDITROPIN FLEXPRO somatropin recombinant INJECTABLE;INJECTION 021148-010 Mar 1, 2010 RX No No   Try a Free Trial   Try a Free Trial Y   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,579,869

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark2002 01169Aug 1, 2002

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Teva
US Army
Mallinckrodt
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.